REDUCED TIME TO GASTROINTESTINAL PROCEDURE AFTER WARFARIN REVERSAL WITH FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) AS COMPARED TO PLASMA IN PATIENTS WITH GASTROINTESTINAL BLEEDING

被引：0
|
作者：
McRae, Hannah L. [1 ]
Spector, Hannah [1 ]
Love, Tanzy [2 ]
Sturpe, Deborah [3 ]
Northam, Kalynn [4 ]
Refaai, Majed A. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Transfus Med Div, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA
[3] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27515 USA
[4] Univ N Carolina, Dept Pharm, Med Ctr, Chapel Hill, NC 27515 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E72 / E72
页数：1
相关论文
共 50 条
  • [1] Reduced Time to Procedure for Gastrointestinal Bleeding After Warfarin Reversal With Four-Factor Complex Concentrate as Compared to Plasma
    Spector, Hannah
    Mcrae, Hannah L.
    Love, Tanzy
    Northam, Kalynn
    Refaai, Khaled
    Rollins-Raval, Marian A.
    Refaai, Majed A.
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2023, 15 (01): : 51 - 57
  • [2] SAFETY OF FOUR FACTOR PROTHROMBIN COMPLEX CONCENTRATES (4F-PCC) FOR THE REVERSAL OF FACTOR XA INHIBITORS
    Tao, Jing
    Bukanova, Elena
    Akhtar, Shamsuddin
    ANESTHESIA AND ANALGESIA, 2018, 126 (04): : 98 - 100
  • [3] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [4] Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals
    Santibanez, M.
    Lesch, C. A.
    Lin, L.
    Berger, K.
    JOURNAL OF CRITICAL CARE, 2018, 48 : 183 - 190
  • [5] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Jing Tao
    Elena N. Bukanova
    Shamsuddin Akhtar
    Journal of Intensive Care, 6
  • [6] Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use
    Uttaro, Elizabeth
    Young, Mikaela R.
    Falvey, Jennifer
    Corvelli, Jenna M.
    Acquisto, Nicole M.
    TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (05)
  • [7] Four-Factor Prothrombin Complex Concentrate (4F-PCC) Effectively Reverses Rivaroxaban Induced Bleeding in a Rabbit Model of Acute Bleeding
    Herzog, Eva
    Mueller-Cohrs, Jochen
    Kaspereit, Franz
    Krege, Wilfried
    Niebl, Peter
    Doerr, Baerbel
    Schulte, Stefan
    Dickneite, Gerhard
    BLOOD, 2014, 124 (21)
  • [8] Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal
    Makhoul, Therese
    Kelly, Gregory
    Kersten, Brian
    Nadler, Megan
    Zammit, Christopher G.
    Jones, Courtney M. C.
    Scott, Rachael
    Acquisto, Nicole M.
    THROMBOSIS RESEARCH, 2020, 194 : 158 - 164
  • [9] Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models
    Ghosh, Subhajit
    Krege, Wilfred
    Doerr, Baerbel
    Mischnik, Marcel
    Pragst, Ingo
    Dickneite, Gerhard
    Herzog, Eva
    PLOS ONE, 2021, 16 (10):
  • [10] Four-Factor Prothrombin Complex Concentrate (4F-PCC) Is Superior to Three-Factor Prothombin Comlex Concentrates (3F-PCC) for Reversal of Coumarin Anticoagulation
    Herzog, Eva
    Kaspereit, Franz
    Krege, Wilfried
    Niebl, Peter
    Schulte, Stefan
    Dickneite, Gerhard
    BLOOD, 2014, 124 (21)
12345